Publications

  1. Nacev BA, Bradic M, Woo HJ, Richards AL, Kelly CM, Dickson MA, Gounder MM, Keohan ML, Chi P, Movva S, Maki RG, Slotkin EK, Rosenbaum E, Avutu V, Chan JE, Banks LB, Adamson T, Singer S, Antonescu CR, Tap WD, Donoghue MT, D'Angelo SP. High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy. J Immunother Cancer. 2025 Sep 5; 13 (9) Epub 2025 Sept 05
    View PubMed
  2. Crane JN, Douglass DP, Oberoi S, Collins NB, Gupta A, Metts JL, Avutu V, Dela Cruz FS, Davis JL, Federman NC, Hiniker SM, Laetsch TW, Linardic CM, Navid F, Saab R, Shulman DS, Shern JF, Soragni A, Stewart EA, Terezakis S, Weigel BJ, Weiss AR. Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group. Eur J Cancer. 2025 Aug 26; 226:115600 Epub 2025 July 06
    View PubMed
  3. Rosenbaum E, Seier K, Bradic M, Movva S, Kelly CM, Dickson MA, Keohan ML, Gounder MM, Chi P, Nacev BA, Chan JE, Avutu V, Biniakewitz M, Jasnani S, Duchemin M, Desir R, Wong P, Erinjeri J, Hwang S, Antonescu CR, Qin LX, Tap WD, D'Angelo SP. A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma. ESMO Open. 2025 Aug; 10 (8):105522 Epub 2025 July 25
    View PubMed
  4. Avutu V, Algazaq JN, Seier K, Desir-Camille R, Qin LX, Babatunde O, Adusumilli PS, Klebanoff CA, Kotecha RR, Shoushtari AN, Slovin S, Warner AB, Park JH, Schoenfeld AJ, O'Cearbhaill R, D'Angelo S, Seo SK. Infections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy. Transplant Cell Ther. 2025 Feb 22 [Epub ahead of print]
    View PubMed
  5. Simhal AK, Firestone RS, Oh JH, Avutu V, Norton L, Hultcrantz M, Usmani SZ, Maclachlan KH, Deasy JO. High WEE1 expression is independently linked to poor survival in multiple myeloma. Blood Cancer J. 2025 Feb 20; 15 (1):22
    View PubMed
  6. Daukshus NP, Avutu V, Long Sarro E, Kinnaman MD, Slotkin EK, Thornton K, Dickson MA, Sklarin NT, Tap WD, Glade Bender J. Harmonization of the Upfront Osteosarcoma Treatment Paradigm for Adolescents and Young Adults. J Adolesc Young Adult Oncol. 2025 Feb; 14 (1):62-67 Epub 2024 July 15
    View PubMed
  7. Slotkin EK, Mauguen A, Dela Cruz FS, Ortiz MV, Avutu V, Meyers PA, Wexler LH, O'Donohue TJ, Kinnaman MD, Kelly CM, D'Angelo SP, Keohan ML, Gounder MM, Thornton K, Nacev BA, Chi P, Rosenbaum E, Dickson M, Pachhal S, Somwar R, Ladanyi M, Robb C, Pandit-Taskar N, Hwang S, Price A, Behr G, Reed DR, Kentsis A, Kung AL, Bender JG, Tap WD. ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results. JCO Oncol Adv. 2025; 2 (1):e2400095 Epub 2025 Apr 28
    View PubMed
  8. Movva S, Seier K, Avutu V, Banks LB, Chan J, Chi P, Dickson MA, Gounder MM, Kelly CM, Keohan ML, Maki R, Rosenbaum E, Salcito T, Rodriguez K, Dempsey R, Meyers PA, Cohen SM, Hensley ML, Konner JA, Schram AM, Lefkowitz RA, Erinjeri JP, Qin LX, Tap WD, D'Angelo SP. Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma. Clin Cancer Res. 2024 Dec 16; 30 (24):5612-5619
    View PubMed
  9. Simhal AK, Firestone R, Oh JH, Avutu V, Norton L, Hultcrantz M, Usmani SZ, Maclachlan KH, Deasy JO. High WEE1 expression is independently linked to poor survival in multiple myeloma. bioRxiv 2024 Sep 24 Epub 2024 Sept 24
    View PubMed
  10. Hesko C, Mittal N, Avutu V, Thomas SM, Heath JL, Roth ME. Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative). Curr Probl Cancer. 2023 Dec; 47 (6):100898 Epub 2022 Sept 28
    View PubMed
  11. Rosenbaum E, Seier K, Bradic M, Kelly C, Movva S, Nacev BA, Gounder MM, Keohan ML, Avutu V, Chi P, Thornton KA, Chan JE, Dickson MA, Donoghue MTA, Tap WD, Qin LX, D'Angelo SP. Immune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced Sarcomas. Cancer Res Commun. 2023 Oct 18; 3 (10):2118-2125
    View PubMed
  12. Kelly CM, Qin LX, Whiting KA, Richards AL, Avutu V, Chan JE, Chi P, Dickson MA, Gounder MM, Keohan ML, Movva S, Nacev BA, Rosenbaum E, Adamson T, Singer S, Bartlett EK, Crago AM, Yoon SS, Hwang S, Erinjeri JP, Antonescu CR, Tap WD, D'Angelo SP. A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma. Clin Cancer Res. 2023 Jun 1; 29 (11):2043-2051
    View PubMed
  13. Avutu V, Weiss AR, Reed DR, Ahmed SK, Allen-Rhoades WA, Chen YE, Davis LE, Eaton BR, Hawkins DS, Indelicato DJ, Patel SR, Randall RL, Reinke DK, Riedel RF, Scharschmidt TJ, Thornton KA, Wang D, Janeway KA, Kopp LM. Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321. J Adolesc Young Adult Oncol. 2022 Jun; 11 (3):328-332 Epub 2021 Sept 09
    View PubMed
  14. Mittal N, Saha A, Avutu V, Monga V, Freyer DR, Roth M. Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials. Sci Rep. 2022 Mar 9; 12 (1):3875 Epub 2022 Mar 09
    View PubMed
  15. Avutu V, Lynch KA, Barnett ME, Vera JA, Glade Bender JL, Tap WD, Atkinson TM. Psychosocial Needs and Preferences for Care among Adolescent and Young Adult Cancer Patients (Ages 15-39): A Qualitative Study. Cancers (Basel). 2022 Jan 29; 14 (3)
    View PubMed
  16. e. Avutu V, Monga V, Mittal N, Saha A, Andolina JR, Bell DE, Fair DB, Flerlage JE, Frediani JN, Heath JL, Kahn JM, Reichek JL, Super L, Terao MA, Freyer DR, Roth ME. Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network. JCO Oncol Pract. 2021 Dec 14:OP2100554. 2021.
    View PubMed
  17. Jee J, Foote MB, Lumish M, Stonestrom AJ, Wills B, Narendra V, Avutu V, Murciano-Goroff YR, Chan JE, Derkach A, Philip J, Belenkaya R, Kerpelev M, Maloy M, Watson A, Fong C, Janjigian Y, Diaz LA Jr, Bolton KL, Pessin MS. Chemotherapy and COVID-19 Outcomes in Patients With Cancer. J Clin Oncol. 2020 Oct 20; 38 (30):3538-3546 Epub 2020 Aug 14
    View PubMed
  18. Eberly LA, Richterman A, Beckett AG, Wispelwey B, Marsh RH, Cleveland Manchanda EC, Chang CY, Glynn RJ, Brooks KC, Boxer R, Kakoza R, Goldsmith J, Loscalzo J, Morse M, Lewis EF, Abel S, Adams A, Anaya J, Andrews EH, Atkinson B, Avutu V, Bachorik A, Badri O, Bailey M, Baird K, Bakshi S, Balaban D, Barshop K, Baumrin E, Bayomy O, Beamesderfer J, Becker N, Berg DD, Berman AN, Blum SM, Boardman AP, Boden K, Bonacci RA, Brown S, Campbell K, Case S, Cetrone E, Charrow A, Chiang D, Clark D, Cohen AJ, Cooper A, Cordova T, Cuneo CN, de Feria AA, Deffenbacher K, DeFilippis EM, DeGregorio G, Deutsch AJ, Diephuis B, Divakaran S, Dorschner P, Downing N, Drescher C, D'Silva KM, Dunbar P, Duong D, Earp S, Eckhardt C, Elman SA, England R, Everett K, Fedotova N, Feingold-Link T, Ferreira M, Fisher H, Foo P, Foote M, Franco I, Gilliland T, Greb J, Greco K, Grewal S, Grin B, Growdon ME, Guercio B, Hahn CK, Hasselfeld B, Haydu EJ, Hermes Z, Hildick-Smith G, Holcomb Z, Holroyd K, Horton L, Huang G, Jablonski S, Jacobs D, Jain N, Japa S, Joseph R, Kalashnikova M, Kalwani N, Kang D, Karan A, Katz JT, Kellner D, Kidia K, Kim JH, Knowles SM, Kolbe L, Kore I, Koullias Y, Kuye I, Lang J, Lawlor M, Lechner MG, Lee K, Lee S, Lee Z, Limaye N, Lin-Beckford S, Lipsyc M, Little J, Loewenthal J, Logaraj R, Lopez DM, Loriaux D, Lu Y, Ma K, Marukian N, Matias W, Mayers JR, McConnell I, McLaughlin M, Meade C, Meador C, Mehta A, Messenger E, Michaelidis C, Mirsky J, Mitten E, Mueller A, Mullur J, Munir A, Murphy E, Nagami E, Natarajan A, Nsahlai M, Nze C, Okwara N, Olds P, Paez R, Pardo M, Patel S, Petersen A, Phelan L, Pimenta E, Pipilas D, Plovanich M, Pong D, Powers BW, Rao A, Ramirez Batlle H, Ramsis M, Reichardt A, Reiger S, Rengarajan M, Rico S, Rome BN, Rosales R, Rotenstein L, Roy A, Royston S, Rozansky H, Rudder M, Ryan CE, Salgado S, Sanchez P, Schulte J, Sekar A, Semenkovich N, Shannon E, Shaw N, Shorten AB, Shrauner W, Sinnenberg L, Smithy JW, Snyder G, Sreekrishnan A, Stabenau H, Stavrou E, Stergachis A, Stern R, Stone A, Tabrizi S, Tanyos S, Thomas C, Thun H, Torres-Lockhart K, Tran A, Treasure C, Tsai FD, Tsaur S, Tschirhart E, Tuwatananurak J, Venkateswaran RV, Vishnevetsky A, Wahl L, Wall A, Wallace F, Walsh E, Wang P, Ward HB, Warner LN, Weeks LD, Weiskopf K, Wengrod J, Williams JN, Winkler M, Wong JL, Worster D, Wright A, Wunsch C, Wynter JS, Yarbrough C, Yau WY, Yazdi D, Yeh J, Yialamas MA, Yozamp N, Zambrotta M, Zon R. Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center. Circ Heart Fail. 2019 Nov; 12 (11):e006214 Epub 2019 Oct 29
    View PubMed
  19. Inaba H, Gaur AH, Cao X, Flynn PM, Pounds SB, Avutu V, Marszal LN, Howard SC, Pui CH, Ribeiro RC, Hayden RT, Rubnitz JE. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia. Cancer. 2014 Jul 1; 120 (13):1985-92 Epub 2014 Mar 26
    View PubMed